Dr. Kishore M. Gadde is a UCI Health physician who primarily conducts clinical research in obesity, type 2 diabetes and other weight-related disorders. His clinical interests include obesity, type 2 diabetes, cardiovascular health and medical weight management.

He is the author of more than 80 peer-reviewed publications and book chapters, and the first or senior author of numerous publications in high-impact journals, including The Lancet, the Journal of the American Medical Association (JAMA), Circulation, the Journal of the American College of Cardiology, the Archives of Internal Medicine, the Annals of Internal Medicine, and Lancet Diabetes & Endocrinology.

Gadde has served as the lead investigator and international coordinating investigator of numerous clinical trials of drugs for obesity, type 2 diabetes and other weight-related metabolic disorders. He has been at the forefront of anti-obesity drug development, serving as the signatory investigator for phase 2 and phase 3 trials of Qsymia, which was approved by the U.S. Food and Drug Administration (FDA) to treat obesity. He presented the trials' safety data to the FDA advisory committee.

For several years, Gadde also was principal site investigator of the Diabetes Prevention Program Outcomes Study for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). He is a standing member of the Veterans Administration endocrinology grant review committee and an ad hoc member of several National Institutes of Health study sections. His current research is funded by a prestigious R01 grant from NIDDK to study treatments for weight regain after bariatric surgery.

He sees patients at the UCI Health Chao Family Comprehensive Digestive Disease Center in Orange.

Services:

• Chao Digestive Health Institute
• Surgery
• Bariatric Surgery

Clinical Interests:

obesity, type 2 diabetes, weight management, weight gain after bariatric surgery